This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1997 Apr 5;349(9057):966-7.

doi: 10.1016/S0140-6736(97)22014-3.

Treating chronic heart failure: time to take stock

J Niebauer¹, A J Coats

Affiliations

PMID: 9100617
DOI: 10.1016/S0140-6736(97)22014-3

Comment

Treating chronic heart failure: time to take stock

J Niebauer et al. Lancet. 1997.

. 1997 Apr 5;349(9057):966-7.

doi: 10.1016/S0140-6736(97)22014-3.

Authors

J Niebauer¹, A J Coats

Affiliation

¹ Imperial College School of Medicine, National Heart & Lung Institute, London, UK.

PMID: 9100617
DOI: 10.1016/S0140-6736(97)22014-3

No abstract available

PubMed Disclaimer

Comment on

Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators.
Hampton JR, van Veldhuisen DJ, Kleber FX, Cowley AJ, Ardia A, Block P, Cortina A, Cserhalmi L, Follath F, Jensen G, Kayanakis J, Lie KI, Mancia G, Skene AM. Hampton JR, et al. Lancet. 1997 Apr 5;349(9057):971-7. doi: 10.1016/s0140-6736(96)10488-8. Lancet. 1997. PMID: 9100622 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information